# Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy

> **NCT01716403** · — · TERMINATED · sponsor: **University Hospital, Grenoble** · enrollment: 8 (actual)

## Conditions studied

- C Hepatitis, Tri Therapy

## Interventions

- **BIOLOGICAL:** Diagnostic: protocol designed to evaluate one or more interventions aimed at identifying a disease or health condition

## Key facts

- **NCT ID:** NCT01716403
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-10
- **Primary completion:** 2014-10
- **Final completion:** —
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716403, "Telaprevir Exposure and Severe Anemia in HCV Infected Patients Treated by Tri-therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01716403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*